TrialBMC cancer2018

Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial.

Susen Burock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.